Education
About Us
Working with TipRanks
Follow Us
AddLife AB Class B (ADDLF)
OTHER OTC:ADDLF
Earnings Data
Report Date
Apr 28, 2026Before Open (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
0.21Last Year’s EPS
0.19Same Quarter Last Year
Based on 0 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone: clear and continuous margin improvement, strong operating cash flow, meaningful net-debt reduction (net debt-to-EBITDA 2.2), and an active, disciplined M&A pipeline. These positives offset material near-term headwinds from currency effects, some weaker instrument and geographic pockets, and one-off impacts from strikes and a divestment/hand-over of a UK endoscopy business. Management emphasized ongoing margin initiatives, portfolio upgrades and confidence in picking up acquisition activity in 2026.Company Guidance
Improved Profitability and Margins
Adjusted EBITA margin improved to 12.4% in the quarter (vs 12.3% a year ago) and the full-year EBITA margin rose to ~12.1% (up from 11.3% the prior year and 10.5% in 2023). Labtech Q4 margin remained strong at 14.1% and Medtech Q4 margin improved to 12.0% (from 11.6%). Full-year margins: Labtech ~12.5% and Medtech ~12.4%.
Strong Cash Generation and Working Capital Performance
Operating cash flow was almost SEK 900 million in the quarter and SEK 1.4 billion for the full year. Working capital contributed SEK 426 million in the quarter, inventory-to-sales improved to 16% (from 17% in 2024), and cash conversion remained high at 111% (98% excluding sale of operations).
Debt Reduction and Balance Sheet Strengthening
Net debt decreased by almost SEK 900 million in 2025 (almost SEK 800 million reduction in the quarter). Net debt-to-EBITDA finished at 2.2 (well below the target of 3) and net debt-to-adjusted EBITA was 2.5, providing capacity for further acquisitions.
Organic and Acquisition-Fueled Growth in 2025
For the full year 2025 organic growth was ~10% and acquired growth contributed ~2%. Total EBITA growth for 2025 was ~8%. In the quarter currency-adjusted sales rose ~2% while adjusted EBITA increased ~5%.
Portfolio & Margin Improvement Initiatives Paying Off
Management reported stronger gross margin driven by price management, higher-margin product mix and new tenders, active pruning of low-margin products, and an increased share of own products—all contributing to the margin improvement trend.
Active M&A Pipeline and Selected Additions
Acquisitions in December included Pharmacold and Opitek (adding refrigeration and patient positioning capabilities). Management indicated a healthy pipeline focused on targets typically between EUR 10–30 million turnover and reiterated discipline on valuation.
ADDLF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
ADDLF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Feb 04, 2026 | $15.20 | $15.20 | 0.00% |
Oct 23, 2025 | $19.84 | $21.51 | +8.42% |
Jul 15, 2025 | $18.78 | $18.77 | -0.08% |
Apr 25, 2025 | $16.33 | $17.06 | +4.45% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does AddLife AB Class B (ADDLF) report earnings?
AddLife AB Class B (ADDLF) is schdueled to report earning on Apr 28, 2026, Before Open (Confirmed).
What is AddLife AB Class B (ADDLF) earnings time?
AddLife AB Class B (ADDLF) earnings time is at Apr 28, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ADDLF EPS forecast?
ADDLF EPS forecast for the fiscal quarter 2026 (Q1) is 0.21.